Additional Proxy Soliciting Materials (definitive) (defa14a)
May 06 2021 - 4:59PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the
Registrant ☒ Filed by a party other than the
Registrant ☐
Check the appropriate box:
|
|
|
|
|
☐
|
|
Preliminary Proxy Statement
|
|
|
|
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
|
|
☐
|
|
Definitive Proxy Statement
|
|
|
|
|
☒
|
|
Definitive Additional Materials
|
|
|
|
|
☐
|
|
Soliciting Material Pursuant to Section 240.14a-12
|
ALLENA
PHARMACEUTICALS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
|
|
|
|
|
|
|
☒
|
|
No fee required.
|
|
|
|
|
☐
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
|
|
(1)
|
|
Title of each class of securities to which transaction applies:
|
|
|
|
(2)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):
|
|
|
|
(4)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
(5)
|
|
Total fee paid:
|
|
|
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
|
|
|
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
|
|
|
|
|
|
|
|
(1)
|
|
Amount previously paid:
|
|
|
|
(2)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
|
(3)
|
|
Filing party:
|
|
|
|
(4)
|
|
Date Filed:
|
One Newton Executive Park
Suite 202
Newton, MA
02462
SUPPLEMENT TO PROXY STATEMENT
FOR THE ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON JUNE 3, 2021
May 6,
2021
Dear Allena Stockholder:
This
proxy statement supplement, dated May 6, 2021, supplements the definitive proxy statement on Schedule 14A (together with subsequent supplements, the “Proxy Statement”) of Allena Pharmaceuticals, Inc. (the
“Company”) that was filed with the Securities and Exchange Commission on April 22, 2021, relating to the Company’s 2021 annual meeting of stockholders to be held on June 3, 2021 (the “2021 Annual
Meeting”). Except as specifically supplemented by the information contained in this proxy statement supplement, all information set forth in the Proxy Statement continues to apply and should be considered in voting your shares.
Appointment of Proxy Solicitor
We have
engaged Georgeson LLC (“Georgeson”) to assist us with the solicitation of proxies in connection with the 2021 Annual Meeting. We expect to pay Georgeson a fee of $20,000, plus reimbursement for certain expenses related to its
services.
|
|
|
Sincerely,
|
|
|
|
|
Louis Brenner, M.D.
|
|
President and Chief Executive Officer, Director
|
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS
FOR THE STOCKHOLDER MEETING TO BE HELD ON JUNE 3, 2021:
This supplement, the Proxy Statement, the Company’s official notice of Annual Meeting of Stockholders and the Company’s 2020 Annual
Report are available at www.voteproxy.com.
Allena Pharmaceuticals (NASDAQ:ALNA)
Historical Stock Chart
From Apr 2024 to May 2024
Allena Pharmaceuticals (NASDAQ:ALNA)
Historical Stock Chart
From May 2023 to May 2024
